Corbus Pharmaceuticals

+$0.00 (+0.01%) As of 4:39 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBP and other ETFs, options, and stocks.

About CRBP

Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes.

CEO
Yuval Cohen
Employees
76
Headquarters
Norwood, Massachusetts
Founded
2009

CRBP Key Statistics

Market Cap
141.52M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
686.36K
High Today
$1.15
Low Today
$1.11
Open Price
$1.11
Volume
264.02K
52 Week High
$4.00
52 Week Low
$0.91

CRBP Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure